Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-28 | Dr. Moore holds a bachelor's degree in Pharmacology with Honors and a Ph.D. in Cell Biology from Manchester University, England. She has held senior roles at Amgen and Genentech. |
| 2021-04-29 | Dr. Moore has served as Chief Technical Officer of Allogene Therapeutics, Inc. and held senior roles at Amgen and Genentech. She holds a Ph.D. in Cell Biology from Manchester University, England. |
| 2022-04-28 | Dr. Moore holds both a bachelor’s degree in Pharmacology with Honors and a Ph.D. in Cell Biology from Manchester University, England. |
| 2023-04-27 | Dr. Moore holds both a bachelor’s degree in Pharmacology with Honors and a Ph.D. in Cell Biology from Manchester University, England. |
| 2024-04-25 | Dr. Moore holds both a bachelor’s degree in Pharmacology with Honors and a Ph.D. in Cell Biology from Manchester University, England. |
Data sourced from SEC filings. Last updated: 2026-02-03